DAE HWA Pharmaceutical Co., Ltd. (KOSDAQ:067080)
South Korea · Delayed Price · Currency is KRW 11,010
+10 (0.09%)
At close: Aug 12, 2026
DAE HWA Pharmaceutical Market Cap
DAE HWA Pharmaceutical has a market cap or net worth of 192.68 billion as of August 12, 2026. Its market cap has decreased by -24.45% in one year.
Market Cap
192.68B
Enterprise Value
292.19B
Revenue
148.75B
Ranking
n/a
PE Ratio
44.36
Stock Price
11,010.00
ChartMarket Cap Chart
Since March 1, 2004, DAE HWA Pharmaceutical's market cap has increased from 15.67B to 192.68B, an increase of 1,129.78%. That is a compound annual growth rate of 11.82%.
| Date | Market Cap | % Change |
|---|---|---|
| Aug 12, 2026 | 192.68B | -36.89% |
| Dec 30, 2025 | 305.32B | 59.32% |
| Dec 30, 2024 | 191.63B | 16.63% |
| Dec 28, 2023 | 164.31B | -0.21% |
| Dec 29, 2022 | 164.66B | 0.86% |
| Dec 30, 2021 | 163.26B | -39.51% |
| Dec 30, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| ImmuneOncia Therapeutics | 309.87B |
| HEM Pharma | 302.12B |
| NOVAREX | 289.00B |
| Cosmax Nbt | 219.94B |
| CellBion | 185.19B |
| Vivozon Pharmaceutical | 177.49B |
| GC WellBeing | 173.82B |
| Ahn-Gook Pharmaceutical | 149.57B |